Advancements in Cancer Treatment: Targeted Therapies and Survival Rates

This chapter explores the paradox of increasing cancer cases alongside a significant decline in mortality rates in the U.S. It emphasizes the promise of antibody drug conjugate technology in delivering targeted therapies, suggesting a hopeful rise in cancer survival rates by 2040.